Favourites   Have ideas?  Sign in / Register

Positive:

Negative:


Disease: Neuropsychiatric segment

ARVN Arvinas, Inc. - Common Stock 2.37% down 10.58% -8.21 + Disease: Neuropsychiatric, Medicine, Disease: Oncology


Last highlighted: #ARVN SEC report: ARVINAS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARVINAS, INC. -- SEC File Number 211148061
+ My List
ZYNE Zynerba Pharmaceuticals, Inc. - Common Stock -8.91% -8.91% 0 + Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric


Last highlighted: #ZYNE SEC report: Zynerba Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Zynerba Pharmaceuticals, Inc. -- SEC File Number 211089272
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.